ePaperEventsR.AGEmStarMajoritiStarPropertyStarCherishStarCarsifuStarSearchmyStarjobKualiKuntumSuriaFM988FM
Karex Bhd is expected to see growth in net profit between now and 2027 driven by a successful commercialisation of its synthetic condoms.
KUALA LUMPUR: Karex Bhd expects the global condom market to outpace global economic growth, driven by rising sexual health awareness and a shift to private sector models.
KUALA LUMPUR: Here is a recap of the announcements that made headlines in Corporate Malaysia.
Karex Bhd’s entry into the synthetic condom market, together with a strategic partnership with a globally known original equipment manufacturer (OEM) of condoms, is expected to boost future earnings and growth prospects as the company plans to expand production capacity.
KUALA LUMPUR: Kenanga Investment Bank Bhd maintained its "outperform" rating on Karex Bhd, setting a share target price of RM1.12 after the United States Food and Drug Administration (FDA) approved its new synthetic condoms.
KUALA LUMPUR: Karex Bhd's 4QFY24 results are expected to meet estimates on growing contribution from high-margin personal lubricant products, which now make up over 15% of the group's turnover, said Kenanga Research.
Karex Bhd’s earnings growth will likely continue to be robust, sustained by strong margins.
PETALING JAYA: Karex Bhd is poised for a good year ahead, capitalising on the rising global demand for condoms that is expected to grow at a compounded annual growth rate (CAGR) of 8% to 9% over the next 10 years.
Karex Bhd is in a good position to beef up its earnings going forward, partly due to a new high-margin product expected to be launched in its financial year 2025 (FY25).
PETALING JAYA: The outlook for condom manufacturer, Karex Bhd, is looking increasingly brighter, underpinned by strong global demand post-lockdowns and a favourable operating environment, said CGS-CIMB Research.
Karex Bhd’s earnings prospects look positive in line with the recovery in demand for condoms, favourable operating environment and new product launches, says CGS-CIMB Research.
KUALA LUMPUR: Karex Bhd posted a net loss of RM2.81mil in the second quarter ended Dec 31, 2021 (2Q22) against a net profit of RM2.79mil.
KUALA LUMPUR: Stocks that could see trading action on Monday include Press Metal, Inari Amertron, IOI Properties, Padini, Dutch Lady, Farm Fresh and Karex, said Apex Research.
KUALA LUMPUR: The world's largest condom maker Karex Bhd is venturing into the business of making medical gloves.
KUALA LUMPUR: Karex Bhd is buying the remaining 30% stake in US-based Global Protection Corp (GP Corp) in a deal worth RM42.26mil that will give its American partner a 7.86% stake in the enlarged group.
PETALING JAYA: Karex Bhd slid into a net loss of RM5.1mil for the fourth quarter (Q4) of its financial year ended June 30, 2021 (FY21) due to higher costs amid the operational disruption caused by the movement control order to contain the Covid-19 pandemic.
KUALA LUMPUR: Condom maker Karex Bhd struggled to maintain its profit in the three-month ended Sept 30 due to Covid-19 restrictions and persistent logistic disruptions.
PETALING JAYA: The recent surge in condom maker Karex Bhd’s share price has put the company under the spotlight.
PETALING JAYA: Karex Bhd has proposed to make Global Protection Corp (GP) its wholly owned subsidiary by acquiring the remaining 30% stake in the US-based condom maker that it does not already own.
